Similarly, soluble podoplanin (sPDPN) has been identified as a biomarker in malignancies and inflammatory diseases such as cancer and COVID-19, highlighting its potential and prognostic significance [14, 15, 16, 17, 18]. Here, PDPN is linked to cancer.